Figure 1.
Retention rates by medication group in the 10-week treatment period. Fewer participants in the BUPRE+BUPRO condition were retained at a lower rate (58%) than those in the BUPRE+PBO (90%), p = .0241.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.